Hypersensitivity, Milk Clinical Trial
Official title:
Pilot Study on the Efficacy and Safety of an Oral Desensitization Protocol at the Onset of Food Allergy
Cow's milk (CM) allergy is the most frequent food allergy in the first years of life, with
prevalence rates estimated in the range of 2-3%.
The elimination of CM is the mainstay of treatment, but accidental exposure to CM proteins is
not uncommon, with a considerable risk of severe allergic reactions.
Recent evidence suggests that early oral exposure in young children may protect to the
development of allergy. On the same way, strategies have been developed for the use of oral
exposure as immunotherapy for the treatment of children with established food allergy even if
available data on the use of oral immunotherapy in infants with food allergy are very
limited.
The aim of this study is to evaluate the feasibility of an oral immunotherapy protocol,
started in the first year of life, in children with CM allergy.
n/a